← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Acelot, Inc.
Santa Barbara, CA
$2,252,809
Total funding
7
Grants
Funding over time
peak $519K · FY2006–16$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$1,952,809 · 5
NSF$300,000 · 2
By mechanism
R44$1,123,234 · 1
R43$829,575 · 4
—$300,000 · 2
Investigators at Acelot, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Scalable tools for the analysis of chemical compounds using graph-based querying$518,950
R44 · FY2008 · MH
Scalable tools for the analysis of chemical compounds using graph-based querying$420,569
R44 · FY2009 · MH
Discovery of LXR Agonists via Pharmacophore Space Mining$223,325
R43 · FY2016 · AG
Scalable tools for the analysis of chemical compounds using graph-based querying$223,300
R43 · FY2007 · GM
Integration and analysis tools for protein interaction networks$199,950
R43 · FY2006 · RR
Scalable tools for the analysis of chemical compounds using graph-based querying$183,715
R44 · FY2010 · MH
Discovery of A-beta Oligomer Antagonists via 3D Pharmacophore Space Analysis$183,000
R43 · FY2012 · GM
SBIR Phase I: Identifying Drug Leads via 3D Pharmacophore Space Analysis$150,000
· FY2012 · TIP
SBIR Phase I: A Learning Drug Discovery Platform in the Cloud$150,000
· FY2014 · TIP